Follow
Luigi Bagella
Luigi Bagella
Professor of Biochemistry, Dept. of Biomedical Sciences, School of Medicine, University
Verified email at uniss.it
Title
Cited by
Cited by
Year
Biological characterization of two novel cathelicidin-derived peptides and identification of structural requirements for their antimicrobial and cell lytic activities
B Skerlavaj, R Gennaro, L Bagella, L Merluzzi, A Risso, M Zanetti
Journal of Biological Chemistry 271 (45), 28375-28381, 1996
3191996
Activation and function of cyclin T–Cdk9 (positive transcription elongation factor-b) in cardiac muscle-cell hypertrophy
M Sano, M Abdellatif, H Oh, M Xie, L Bagella, A Giordano, LH Michael, ...
Nature medicine 8 (11), 1310-1317, 2002
2722002
The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian virus-40 large T-antigen in human mesotheliomas
A De Luca, A Baldi, V Esposito, CM Howard, L Bagella, P Rizzo, M Caputi, ...
Nature medicine 3 (8), 913-916, 1997
2521997
From G0 to S phase: A view of the roles played by the retinoblastoma (Rb) family members in the Rb‐E2F pathway
A Sun, L Bagella, S Tutton, G Romano, A Giordano
Journal of cellular biochemistry 102 (6), 1400-1404, 2007
2142007
cDNA sequences of three sheep myeloid cathelicidins
L Bagella, M Scocchi, M Zanetti
FEBS letters 376 (3), 225-228, 1995
1431995
Histone deacetylase inhibitors in the treatment of hematological malignancies and solid tumors
M Federico, L Bagella
BioMed Research International 2011 (1), 475641, 2011
1382011
Activation of MyoD-dependent transcription by cdk9/cyclin T2
C Simone, P Stiegler, L Bagella, B Pucci, C Bellan, G De Falco, ...
Oncogene 21 (26), 4137-4148, 2002
1302002
The COOH-terminal region of pRb2/p130 binds to histone deacetylase 1 (HDAC1), enhancing transcriptional repression of the E2F-dependent cyclin A promoter
P Stiegler, A De Luca, L Bagella, A Giordano
Cancer research 58 (22), 5049-5052, 1998
1301998
Viral infections as a cause of cancer
C Carrillo-Infante, G Abbadessa, L Bagella, A Giordano
International journal of oncology 30 (6), 1521-1528, 2007
1282007
Ezh2 reduces the ability of HDAC1-dependent pRb2/p130 transcriptional repression of cyclin A
T Tonini, L Bagella, G D'Andrilli, PP Claudio, A Giordano
Oncogene 23 (28), 4930-4937, 2004
1152004
A unique domain of pRb2/p130 acts as an inhibitor of Cdk2 kinase activity
A De Luca, TK MacLachlan, L Bagella, C Dean, CM Howard, PP Claudio, ...
Journal of Biological Chemistry 272 (34), 20971-20974, 1997
1131997
CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation
C Bellan, G De Falco, S Lazzi, P Micheli, S Vicidomini, K Schürfeld, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2004
962004
Study of viral integration of HPV-16 in young patients with LSIL
G Gallo, M Bibbo, L Bagella, A Zamparelli, F Sanseverino, MR Giovagnoli, ...
Journal of clinical pathology 56 (7), 532-536, 2003
962003
Importance of Ezh2 polycomb protein in tumorigenesis process interfering with the pathway of growth suppressive key elements
T Tonini, G D'Andrilli, A Fucito, L Gaspa, L Bagella
Journal of cellular physiology 214 (2), 295-300, 2008
872008
Physical interaction between pRb and cdk9/cyclinT2 complex
C Simone, L Bagella, C Bellan, A Giordano
Oncogene 21 (26), 4158-4165, 2002
862002
Retinoblastoma tumor-suppressor protein phosphorylation and inactivation depend on direct interaction with Pin1
F Rizzolio, C Lucchetti, I Caligiuri, I Marchesi, M Caputo, AJ Klein-Szanto, ...
Cell Death & Differentiation 19 (7), 1152-1161, 2012
822012
Frequent loss of pRb2/p130 in human ovarian carcinoma
G D’Andrilli, V Masciullo, L Bagella, T Tonini, C Minimo, GF Zannoni, ...
Clinical cancer research 10 (9), 3098-3103, 2004
702004
MyoD recruits the cdk9/cyclin T2 complex on myogenic‐genes regulatory regions
C Giacinti, L Bagella, PL Puri, A Giordano, C Simone
Journal of cellular physiology 206 (3), 807-813, 2006
682006
Cloning of murine CDK9/PITALRE and its tissue‐specific expression in development
L Bagella, TK MacLachlan, RJ Buono, MM Pisano, A Giordano, ...
Journal of cellular physiology 177 (2), 206-213, 1998
681998
A small molecule based on the pRb2/p130 spacer domain leads to inhibition of cdk2 activity, cell cycle arrest and tumor growth reduction in vivo
L Bagella, A Sun, T Tonini, G Abbadessa, G Cottone, MG Paggi, ...
Oncogene 26 (13), 1829-1839, 2007
612007
The system can't perform the operation now. Try again later.
Articles 1–20